Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveChicago Fed's Goolsbee Calls September Inflation 'Discouraging' But Favors Waiting On More Data

Live News CENTRAL_BANK FLASH H impact Oct 14, 2026, 07:09 PM UTC

Chicago Fed's Goolsbee Calls September Inflation 'Discouraging' But Favors Waiting On More Data

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

A resurgence in oil prices dragged down stocks and bonds, raising inflation concerns just days before the Federal Reserve's interest rate decision. H impact | CENTRAL_BANK | Oct 23, 2026, 04:10 PM UTC POLL: BoC To Raise Overnight Rate To 2.50% On October 28, Said 19 Of 34 Economists BoC To Hike Twice By End-March, Said 16 Of 29 Economists (Vs 17 Of 34 Forecasting Hold Until Mid-2027 In August Poll) L impact | CENTRAL_BANK | Oct 23, 2026, 04:07 PM UTC Poll: Bank of Canada to hike overnight rate twice by end-March, said 16 of 29 economists (vs 17 of 34 forecasting hold until mid-2027 in August poll). L impact | CENTRAL_BANK | Oct 23, 2026, 04:06 PM UTC Poll: The Bank of Canada to raise overnight rate to 2.50% on October 28th, said 19 of 34 economists. L impact | CENTRAL_BANK | Oct 23, 2026, 04:06 PM UTC Brazil’s 10-Year Yield Edges Higher Ahead of Election Runoff Brazil’s 10-year government bond yield edged higher, rising above 13% in October amid election uncertainty ahead of the presidential runoff. A Datafolha poll showed Senator Flávio H impact | CENTRAL_BANK | Oct 23, 2026, 03:51 PM UTC Novartis: Remibrutinib Meets Primary Endpoints In Phase 3 Trials In RMS Cuts RMS Relapse Rate By 35% Versus Rival - To Seek Global Approval For Remibrutinib In RMS L impact | CENTRAL_BANK | Oct 23, 2026, 03:46 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.